Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-11-15 Sale |
2021-11-16 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3 | $187.26 | $562 | 41,243 (Indirect Direct) |
View |
| 2021-05-17 Sale |
2021-05-19 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Comm & Ops Officer |
109 | $216.41 | $23,589 | 41,243 (Indirect Direct) |
View |
| 2021-02-25 Sale |
2021-02-26 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
3,634 | $213.54 | $775,989 | 41,243 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
7,825 | $211.82 | $1,657,481 | 47,775 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-16 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
5,156 | $210.55 | $1,085,593 | 61,840 (Indirect Direct) |
View |
| 2021-02-03 Sale |
2021-02-05 4:43 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $213.74 | $332,146 | 70,097 (Indirect Direct) |
View |
| 2020-11-16 Sale |
2020-11-18 4:11 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
7 | $223.64 | $1,565 | 35,319 (Indirect Direct) |
View |
| 2020-11-03 Sale |
2020-11-05 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $211.92 | $329,115 | 36,873 (Indirect Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:17 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $278.39 | $432,337 | 38,426 (Indirect Direct) |
View |
| 2020-07-07 Sale |
2020-07-09 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
2,786 | $300 | $835,800 | 61,086 (Indirect Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
113 | $283.98 | $32,089 | 35,319 (Indirect Direct) |
View |
| 2020-05-04 Sale |
2020-05-06 4:38 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $260.76 | $404,957 | 39,979 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-10 Tax Withholding |
2022-02-14 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,040 | $237.74 | 76,578 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
38,375 | $0 | 79,618 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:24 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
15,000 | $0 | 92,000 (Direct) |
View |
| 2021-06-16 Option Award |
2021-06-17 4:24 pm |
N/A 2031-06-16 |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
44,000 | $6.77 | 92,000 (Direct) |
View |
| 2021-06-09 Option Award |
2021-06-11 4:06 pm |
N/A 2031-06-08 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2021-02-24 Tax Withholding |
2021-02-26 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
2,898 | $217.57 | 41,243 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
6,240 | $211.75 | 47,775 (Direct) |
View |
| 2021-02-10 Tax Withholding |
2021-02-12 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
3,101 | $214.16 | 66,996 (Direct) |
View |
| 2021-02-03 Option Award |
2021-02-05 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
34,778 | $0 | 70,097 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-05 4:43 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $0 | 70,097 (Direct) |
View |
| 2021-02-03 Exercise |
2021-02-05 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,554 | $86.52 | 70,097 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 4:16 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 36,873 (Direct) |
View |
| 2020-11-03 Exercise |
2020-11-05 4:16 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 36,873 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 38,426 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 38,426 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:13 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
2,786 | $0 | 61,086 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,564 | $187.53 | 61,086 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,222 | $155.57 | 61,086 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-18 5:26 pm |
N/A 2030-06-16 |
RHYTHM PHARMACEUTICALS INC. | RYTM | Arbuckle Stuart A Director |
18,500 | $0 | 18,500 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-18 4:06 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
17,000 | $0 | 83,000 (Direct) |
View |
| 2020-06-17 Option Award |
2020-06-18 4:06 pm |
N/A 2030-06-17 |
ImmunoGen Inc. | IMGN | Arbuckle Stuart A Director |
50,000 | $4.56 | 83,000 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 4:38 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $0 | 39,979 (Direct) |
View |
| 2020-05-04 Exercise |
2020-05-06 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, Chief Commercial Officer |
1,553 | $86.52 | 39,979 (Direct) |
View |